Laboratory medicine quality indicators : A review of the literature

American Journal of Clinical Pathology

Volumn 131, Issue 3, 2009, Pages 418-431

  Shahangian, Shahram ^a,b   Snyder, Susan R ^a  

^a NATIONAL CENTER FOR PREPAREDNESS DETECTION AND CONTROL OF INFECTIOUS DISEASES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Health outcome; Laboratory medicine; Laboratory test utilization; Laboratory service delivery; Quality indicator; Quality measure

Indexed keywords

BIOPSY; BLOOD CULTURE; CONTAMINATION; CYTOLOGY; EVIDENCE BASED PRACTICE; HEALTH CARE ACCESS; HEALTH CARE QUALITY; HUMAN; INFORMATION PROCESSING; LABORATORY; LABORATORY DIAGNOSIS; LABORATORY TEST; PATIENT CARE; PATIENT IDENTIFICATION; PATIENT SAFETY; PATIENT SATISFACTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; TURNAROUND TIME; STANDARD;

GUIDELINES AS TOPIC; HUMANS; LABORATORIES; QUALITY INDICATORS, HEALTH CARE; QUALITY OF HEALTH CARE;

EID: 62449153784     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/AJCPJF8JI4ZLDQUE     Document Type: Review

References (140)

1. Lundberg GD. Acting on significant laboratory results. JAMA. 1981;245:1762-1763.
2. Clinical and Laboratory Standards Institute. Application of a Quality Management System Model for Laboratory Services. 3rd ed. Wayne, PA; CLSI; 2004. Document GP26-A3.
3. College of American Pathologists. About Q-Tracks. http://www.cap.org/ apps/cap.portal?-nfpb=true&cntvwrPtlt-actionOverride= %2Fportlets%2FcontentViewer%2Fshow&-windowLabel=cntvwrPtlt& cntvwrPdt%7BactionForm. contentReference%7D=q-tracks%2Fq-tracksdesc.html&- state=maximized&-pageLabel=cntvwr. Updated January 2, 2009. Accessed January 24, 2009.
4. The Joint Commission. 2009 national patient safety goals: laboratory services program, http://www.jointcommission.org/patientsafety/ nationalpatientsafetygoals/09-lab-npsgs.htm. Accessed January 24, 2009.
5. Institute of Medicine Committee to Design a Strategy for Quality Review and Assurance in Medicare. Medicare: A Strategy for Quality Assurance. Washington, DC: National Academies Press; 1990.
6. Agency for Healthcare Research and Quality. National Quality Measures Clearinghouse: desirable measure attributes, http://www.qualitymeasures.ahrq. gov/ resources/ measure-use. aspx#attributes. Updated January 19, 2009. Accessed January 24, 2009.
7. Institute of Medicine Committee on Quality of Health Care in America. To Err Is Human: Building a Safer Health System. Washington, DC: National Academies Press; 2000.
8. Agency for Healthcare Research and Quality. National Quality Measures Clearinghouse: measure archive. http://www.qualitymeasures.ahrq.gov/resources/ summaryarchive.aspx. Updated January 19, 2009. Accessed January 24, 2009.
9. Agency for Healthcare Research and Quality. National Guideline Clearinghouse. http://www.guideline.gov/browse/browsecondition.aspx. Updated January 19, 2009. Accessed January 24, 2009.
10. Agency for Healthcare Research and Quality. National Healthcare Quality Report. http://www.ahrq.gov/qual/nhqr07/nhqr07.pdf. February 2008. Accessed January 24, 2009.
11. College of American Pathologists. Past Q-Probes studies. http://www.cap.org/apps/ cap.portal?-nfpb=true&cntvwrPtlt-actionOverride= %2Fportlets%2FcontentViewer%2Fshow&-windowLabel=cntvwrPtlt&- cntvwrPdt%7BactionForm.contentReference%7D=q-probes%2Fpaststudies. html&-state=maximized&-pageLabel=cntvwr. Updated December 8, 2008. Accessed January 24, 2009.
12. National Committee for Quality Assurance. Measuring quality: improving health, http://web.ncqa.org/tabid/661/default.aspx. Accessed January 24, 2009.
13. Agency for Healthcare Research and Quality. US Preventive Services Task Force (USPSTF). http://www.ahrq.gov/clinic/uspstfix.htm. Accessed January 24, 2009.
14. Centers for Disease Control and Prevention. MMWR Morbidity and Mortality Weekly Report. MMWR recommendations and reports: current volume. http://www.cdc.gov/mmwr/mmwr-rr.html. Accessed January 24, 2009.
15. Centers for Disease Control and Prevention. MMWR Morbidity and Mortality Weekly Report. MMWR recommendations and reports: past volumes. http://www.cdc.gov/mmwr/recreppy.html. Accessed January 24, 2009.
16. Guide to Community Preventive Services. The community guide.http://www.thecommunityguide.org. Updated December 23, 2008. Accessed January 24, 2009.
17. Agency for Healthcare Research and Quality. National Quality Measures Clearinghouse: inclusion criteria. http://www.qualitymeasures.org/about/ inclusion.aspx. Updated January 19, 2009. Accessed January 24, 2009.
18. Merlani P, Garnerin P, Diby M, et al. Quality improvement report: linking guideline to regular feedback to increase appropriate requests for clinical tests: blood gas analysis in intensive care. BMJ. 2001;323:620-624.
19. Ozbek OA, Oktem MA, Dogan G, et al. Application of hepatitis serology testing algorithms to assess inappropriate laboratory utilization. J Eval Clin Pract. 2004;10:519-523.
20. Bates DW, Boyle DL, Rittenberg E, et al. What proportion of common diagnostic tests appear redundant? Am J Med. 1998;104:361-368.
21. Bates DW, Kuperman GJ, Rittenberg E, et al. A randomized trial of a computer-based intervention to reduce utilization of redundant laboratory tests. Am J Med. 1999;106:144-150.
22. Valenstein P, Schifman RB. Duplicate laboratory orders: a College of American Pathologists Q-Probes study of thyrotropin requests in 502 institutions. Arch Pathol Lab Med. 1996;120:917-921.
23. Behal R. Identification of performance measures of importance for quality in laboratory medicine. http://qualityforum.org/pdf/projects/lab-med/ txlabpaper-behal-final%2005-21-07. pdf. December 2006. Accessed January 24, 2009.
24. Shea S, Sideli RV, DuMouchel W, et al. Computer-generated informational messages directed to physicians: effect on length of hospital stay. J Am Med Inform Assoc. 1995;2:58-64.
25. Tierney WM, Miller ME, Overhage JM, et al. Physician inpatient order writing on microcomputer workstations: effects on resource utilization. JAMA. 1993;269:379-383.
26. Tierney WM, Miller ME, McDonald CJ. The effect on test ordering of informing physicians of the charges for outpatient diagnostic tests. N Engl J Med. 1990;322:1499-1504.
27. Neilson EG, Johnson KB, Rosenbloom ST, et al. The impact of peer management on test-ordering behavior. Ann Intern Med. 2004;141:196-204.
28. Wang TJ, Mort EA, Nordberg P, et al. A utilization management intervention to reduce unnecessary testing in the coronary care unit. Arch Intern Med. 2002;162:1885-1890.
29. Hampers LC, Cha S, Gutglass DJ, et al. The effect of price information on test-ordering behavior and patient outcomes in a pediatric emergency department. Pediatrics. 1999;103:877-882.
30. US Preventive Services Task Force. The guide to clinical preventive services 2008: recommendations of the US Preventive Services Task Force, http://www.ahrq.gov/clinic/pocketgd08/pocketgd08.pdf. September 2008. Accessed January 24, 2009.
31. Morrow DA, Cannon CP, Jesse RL, et al. National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Circulation. 2007;115:e356-e375. http://circ.ahajournals.org/cgi/reprint/ 115/13/ e356. Accessed January 24, 2009.
32. Tang WH, Francis GS, Morrow DA, et al. National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines: clinical utilization of cardiac biomarker testing in heart failure. Circulation. 2007;116:e99-el09. http://circ.ahajournals.org/cgi/reprint/116/5/e99. Accessed January 24, 2009.
33. Stratton IM, Adler Al, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321:405-412.
34. van Walraven C, Goel V, Chan B. Effect of population-based interventions on laboratory utilization: a time-series analysis. JAMA. 1998;280:2028-2033.
35. Verstappen WHJM, van der Weijden T, Sijbrandij J, et al. Effect of a practice-based strategy on test ordering performance of primary care physicians: a randomized trial. JAMA. 2003;289:2407-2412.
36. Sucov A, Bazarian JJ, de Lahunta EA, et al. Test ordering guidelines can alter ordering patterns in an academic emergency department. J Emerg Med. 1999;17:391-397.
37. Bunting PS, van Walraven C. Effect of a controlled feedback intervention on laboratory test ordering by community physicians. Clin Chem. 2004;50:321-326.
38. Winkens RAG, Pop P, Grol RPTM, et al. Effect of feedback on test ordering behaviour of general practitioners. BMJ. 1992;304:1093-1096.
39. Winkens RAG, Pop P, Bugter-Maessen AMA, et al. Randomised controlled trial of routine individual feedback to improve rationality and reduce numbers of test requests. Lancet. 1995;345:498-502.
40. Winkens RAG, Ament AJHA, Pop P, et al. Routine individual feedback on requests for diagnostic tests: an economic evaluation. Med Decis Making. 1996; 16:309-314.
41. Durieux P, Ravaud P, Porcher R, et al. Long-term impact of a restrictive laboratory test ordering form on tumor marker prescriptions. Int J Technol Assess Health Care. 2003;19:106-113.
42. Poley MJ, Edelenbos KI, Mosseveld M, et al. Cost consequences of implementing an electronic decision support system for ordering laboratory tests in primary care: evidence from a controlled prospective study in the Netherlands. Clin Chem. 2007;53:213-219.
43. Smith BJ, McNeely MDD. The influence of an expert system for test ordering and interpretation on laboratory investigations. Clin Chem. 1999;45:1168-1175.
44. Overhage JM, Tierney WM, Zhou XH, et al. A randomized trial of "corollary orders" to prevent errors of omission. J Am Med Inform Assoc. 1997;4:364-375.
45. Dale JC, Renner SW. Wristband errors in small hospitals: a College of American Pathologists' Q-Probes study of quality issues in patient identification. Lab Med. 1997;28:203-207.
46. Howanitz PJ, Renner SW, Walsh MK. Continuous wristband monitoring over 2 years decreases identification errors: a College of American Pathologists Q-Tracks study. Arch Pathol Lab Med. 2002;126:809-815.
47. Novis DA, Miller KA, Howanitz PJ, et al. Audit of transfusion procedures in 660 hospitals: a College of American Pathologists Q-Probes study of patient identification and vital sign monitoring frequencies in 16494 transfusions. Arch Pathol Lab Med. 2003;127:541-548.
48. Renner SW, Howanitz PJ, Bachner P. Wristband identification error reporting in 712 hospitals: a College of American Pathologists Q-Probes study of quality issues in transfusion practice. Arch Pathol Lab Med. 1993;117:573-577.
49. Linden JV, Wagner K, Voytovich AE, et al. Transfusion errors in New York State: an analysis of 10 years' experience. Transfusion. 2000;40:1207-1213.
50. Valenstein PN, Raab SS, Walsh MK. Identification errors involving clinical laboratories: a College of American Pathologists Q-Probes study of patient and specimen identification errors at 120 institutions. Arch Pathol Lab Med. 2006;130:1106-1113.
51. Linden JV, Paul B, Dressier KP. A report of 104 transfusion errors in New York State. Transfusion. 1992;32:601-606.
52. Valenstein PN, Sirota RL. Identification errors in pathology and laboratory medicine. Clin Lab Med. 2004;24:979-996.
53. Williamson LM, Lowe S, Love EM, et al. Serious Hazards of Transfusion (SHOT) initiative: analysis of the first two annual reports. BMJ. 1999;319:16-19.
54. Mercuriali F, Inghilleri G, Colotti MT, et al. Bedside transfusion errors: analysis of 2 years' use of a system to monitor and prevent transfusion errors. Vox Sang. 1996;70:16-20.
55. Dale JC, Novis DA. Outpatient phlebotomy success and reasons for specimen rejection. Arch Pathol Lab Med. 2002;126:416-419.
56. Howanitz PJ, Cembrowski GS, Bachner P. Laboratory phlebotomy: College of American Pathologists Q-Probe study of patient satisfaction and complications in 23783 patients. Arch Pathol Lab Med. 1991;115:867-872.
57. Howanitz PJ, Schifman RB. Inpatient phlebotomy practices: a College of American Pathologists Q-Probes quality improvement study of 2351643 phlebotomy requests. Arch Pathol Lab Med. 1994;118:601-605.
58. Dale JC, Howanitz PJ. Patient satisfaction in phlebotomy: a College of American Pathologists Q-Probes study. Lab Med. 1996;27:188-192.
59. Stark A, Jones BA, Chapman D, et al. Clinical laboratory specimen rejection: association with the site of patient care and patients' characteristics. Arch Pathol Lab Med. 2007;131:588-592.
60. Jones BA, Calam RR, Howanitz PJ. Chemistry specimen acceptability: a College of American Pathologists Q-Probes study of 453 laboratories. Arch Pathol Lab Med. 1997;121:19-26.
61. Jones BA, Meier F, Howanitz PJ. Complete blood count specimen acceptability: a College of American Pathologists Q-Probes study of 703 laboratories. Arch Pathol Lab Med. 1995;119:203-208.
62. Schifman RB, Strand CL, Meier FA, et al. Blood culture contamination: a College of American Pathologists Q-Probes study involving 640 institutions and 497134 specimens from adult patients. Arch Pathol Lab Med. 1998;122:216-221.
63. Bates DW, Goldman L, Lee TH. Contaminant blood cultures and resource utilization: the true consequences of false-positive results. JAMA. 1991;265:365-369.
64. Little JR, Murray PR, Traynor PS, et al. A randomized trial of povidone-iodine compared with iodine tincture for venipuncture site disinfection: effects on rates of blood culture contamination. Am J Med. 1999;107:119-125.
65. Norberg A, Christopher NC, Ramundo ML, et al. Contamination rates of blood cultures obtained by dedicated phlebotomy vs intravenous catheter. JAMA. 2003;289:726-729.
66. Shafazand S, Weinacker AB. Blood cultures in the critical care unit: improving utilization and yield. Chest. 2002;122:1727-1736.
67. Surdulescu S, Utamsingh D, Shekar R. Phlebotomy teams reduce blood-culture contamination rate and save money. Clin Perform Qual Health Care. 1998;6:60-62.
68. Bekeris LG, Tworek JA, Walsh MK, et al. Trends in blood culture contamination: a College of American Pathologists Q-Tracks study of 356 institutions. Arch Pathol Lab Med. 2005;129:1222-1225.
69. Weinbaum FI, Lavie S, Danek M, et al. Doing it right the first time; quality improvement and the contaminant blood culture. J Clin Microbiol. 1997;35:563-565.
70. Weinstein MP. Blood culture contamination: persisting problems and partial progress. J Clin Microbiol. 2003;41:2275-2278.
71. Nakhleh RE, Zarbo RJ. Surgical pathology specimen identification and accessioning: a College of American Pathologists Q-Probes study of 1004115 cases from 417 institutions. Arch Pathol Lab Med. 1996;120:227-233.
72. Howanitz PJ. Errors in laboratory medicine: practical lessons to improve patient safety. Arch Pathol Lab Med. 2005;129:1252-1261.
73. Makary MA, Epstein J, Pronovost PJ, et al. Surgical specimen identification errors: a new measure of quality in surgical care. Surgery. 2007;141:450-455.
74. Laboratory Requirements: Clinical Laboratory Improvement Amendments of 1988. 42 USC (1988). http://wwwn.cdc.gov/clia/pdf/42cfr493-2004.pdf. Accessed January 24, 2009.
75. Parsons PJ, Reilly AA, Esernio-Jenssen D, et al. Evaluation of blood lead proficiency testing: comparison of open and blind paradigms. Clin Chem. 2001;47:322-330.
76. Reilly AA, Salkin IF, McGinnis MR, et al. Evaluation of mycology laboratory proficiency testing. J Clin Microbiol. 1999;37:2297-2305.
77. Jenny RW, Jackson KY. Proficiency test performance as a predictor of accuracy of routine patient testing for theophylline. Clin Chem. 1993;39:76-81.
78. Keenlyside RA, Collins CL, Hancock JS, et al. Do proficiency test results correlate with the work performance of screeners who screen Papanicolaou smears? Am J Clin Pathol. 1999;112:769-776.
79. Edson DC, Massey LD. Proficiency testing performance in physician's office, clinic and small hospital laboratories, 1994-2004. Lab Med. 2007;38:237-239.
80. Government Accountability Office. Clinical lab quality: CMS and survey organization oversight should be strengthened. http://www.gao.gov/new.items/ d06416.pdf. June 2006. Accessed January 24, 2009.
81. Novak RW. Do proficiency testing participants learn from their mistakes? Experience from the EXCEL throat culture module. Arch Pathol Lab Med. 2002;126:147-149.
82. Raab SS. Improving patient safety through quality assurance. Arch Pathol Lab Med. 2006;130:633-637.
83. Zarbo RJ, Jones BA, Friedberg RC, et al. Q-Tracks: a College of American Pathologists program of continuous laboratory monitoring and longitudinal tracking. Arch Pathol Lab Med. 2002;126:1036-1044.
84. Raab SS, Grzybicki DM, Zarbo RJ, et al. Anatomic pathology databases and patient safety. Arch Pathol Lab Med. 2005;129:1246-1251.
85. Clary KM, Silverman JF, Liu Y, et al. Cytohistologic discrepancies: a means to improve pathology practice and patient outcomes. Am J Clin Pathol. 2002;117:567-573.
86. Selvaggi SM. Implications of low diagnostic reproducibility of cervical cytologic and histologic diagnoses. JAMA. 2001;285:1506-1508.
87. Stoler MH, Schiffman M. Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study. JAMA. 2001,285:15004505.
88. Jones BA, Novis DA. Cervical biopsy-cytology correlation: a College of American Pathologists Q-Probes study of 22439 correlations in 348 laboratories. Arch Pathol Lab Med. 1996;120:523-531.
89. Novis DA, Dale JC. Morning rounds inpatient test availability: a College of American Pathologist Q-Probes study of 79860 morning complete blood cell count and electrolyte test results in 367 institutions. Arch Pathol Lab Med. 2000;124:499-503.
90. Dale JC, Steindel SJ, Walsh M. Early morning blood collections: a College of American Pathologists Q-Probes study of 657 institutions. Arch Pathol Lab Med. 1998;122:865-870.
91. Nakhleh RE, Zarbo RJ. Amended reports in surgical pathology and implications for diagnostic error detection and avoidance: a College of American Pathologists Q-Probes study of 1667547 accessioned cases in 359 laboratories. Arch Pathol Lab Med. 1998;122:303-309.
92. Yuan S, Astion ML, Schapiro J, et al. Clinical impact associated with corrected results in clinical microbiology testing. J Clin Microbiol. 2005;43:2188-2193.
93. Wagar EA, Stankovic AK, Wilkinson DS, et al. Assessment monitoring of laboratory critical values: a College of American Pathologists Q-Tracks study of 180 institutions. Arch Pathol Lab Med. 2007;131:44-49.
94. Dighe AS, Rao A, Coakley AB, et al. Analysis of laboratory critical value reporting at a large academic medical center. Am J Clin Pathol. 2006;125:758-764.
95. Hanna D, Griswold P, Leape LL, et al. Communicating critical test results: safe practice recommendations. Jt Comm J Qual Patient Saf. 2005;31:68-80.
96. Howanitz PJ, Steindel SJ, Heard NV. Laboratory critical values policies and procedures: a College of American Pathologists Q-Probes study in 623 institutions. Arch Pathol Lab Med. 2002;126:663-669.
97. Wagar EA, Friedberg RC, Souers R, et al. Critical values comparison: a College of American Pathologists Q-Probes survey of 163 clinical laboratories. Arch Pathol Lab Med. 2007;131:1769-1775.
98. Tate KE, Gardner RM. Computers, quality, and the clinical laboratory: a look at critical value reporting. Proc Annu Symp Comput Appl Med Care. 1993; 193-197.
99. Emancipator K. Critical values: ASCP practice parameter: American Society of Clinical Pathologists. Am J Clin Pathol. 1997;108:247-253.
100. Kuperman GJ, Boyle D, Jha A, et al. How promptly are inpatients treated for critical laboratory results? J Am Med Inform Assoc. 1998;5:112-119.
101. Bonini P, Plebani M, Ceriotti F, et al. Errors in laboratory medicine. Clin Chem. 2002;48:691-698.
102. Steindel SJ, Howanitz PJ. Physician satisfaction and emergency department laboratory test turnaround time. Arch Pathol Lab Med. 2001;125:863-871.
103. Howanitz PJ, Cembrowski GS, Steindel SJ, et al. Physician goals and laboratory test turnaround times: a College of American Pathologists Q-Probes study of 2763 clinicians and 722 institutions. Arch Pathol Lab Med. 1993;117:22-28.
104. Jones BA, Novis DA. Nongynecologic cytology turnaround time: a College of American Pathologists Q-Probes study of 180 laboratories. Arch Pathol Lab Med. 2001;125:1279-1284.
105. Jones BA, Valenstein PN, Steindel SJ. Gynecologic cytology turnaround time: a College of American Pathologists Q-Probes study of 371 laboratories. Arch Pathol Lab Med. 1999;123:682-686.
106. Kilgore ML, Steindel SJ, Smith JA. Evaluating stat testing options in an academic health center: therapeutic turnaround time and staff satisfaction. Clin Chem. 1998;44:1597-1603.
107. Novis DA, Jones BA, Dale JC, et al. Biochemical markers of myocardial injury test turnaround time: a College of American Pathologists Q-Probes study of 7020 troponin and 4368 creatine kinase-MB determinations in 159 institutions. Arch Pathol Lab Med. 2004;128:158-164.
108. Steindel SJ. Timeliness of clinical laboratory tests: a discussion based on five College of American Pathologists Q-Probes studies. Arch Pathol Lab Med. 1995;119:918-923.
109. Steindel SJ, Jones BA. Routine outpatient laboratory test turnaround times and practice patterns: a College of American Pathologists Q-Probes study. Arch Pathol Lab Med. 2002;126:11-18.
110. Steindel SJ, Novis DA. Using outlier events to monitor test turnaround time. Arch Pathol Lab Med. 1999;123:607-614.
111. Valenstein P, Walsh M. Five-year follow-up of routine outpatient test turnaround time: a College of American Pathologists Q-Probes study. Arch Pathol Lab Med. 2003;127:1421-1423.
112. Ryan TJ, Antman EM, Brooks NH, et al. 1999 update: ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction: executive summary and recommendations: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). Circulation. 1999;100:1016-1030.
113. Novis DA, Walsh MK, Dale JC, et al. Continuous monitoring of stat and routine outlier turnaround times: two College of American Pathologists Q-Tracks monitors in 291 hospitals. Arch Pathol Lab Med. 2004;128:621-626.
114. Bluth EI, Lambert DJ, Lohmann TP, et al. Improvement in "stat" laboratory turnaround time: a model continuous quality improvement project. Arch Intern Med. 1992;152:837-840.
115. Lee-Lewandrowski E, Corboy D, Lewandrowski K, et al. Implementation of a point-of-care satellite laboratory in the emergency department of an academic medical center: impact on test turnaround time and patient emergency department length of stay. Arch Pathol Lab Med. 2003;127:456-460.
116. Holland LL, Smith LL, Blick KE. Reducing laboratory turnaround time outliers can reduce emergency department patient length of stay: an 11-hospital study. Am J Clin Pathol. 2005;124:672-674.
117. Singer AJ, Ardise J, Gulla J, et al. Point-of-care testing reduces length of stay in emergency department chest pain patients. Ann EmergMed. 2005;45:587-591.
118. Holland LL, Smith LL, Blick KE. Total laboratory automation can help eliminate the laboratory as a factor in emergency department length of stay. Am J Clm Pathol. 2006;125:765-770.
119. Fitch JC, Mirto GP, Geary KL, et al Point-of-care and standard laboratory coagulation testing during cardiovascular surgery: balancing reliability and timeliness. J Clin Monit Comput. 1999;15:197-204.
120. Lewandrowski K. How the clinical laboratory and the emergency department can work together to move patients through quickly. Clin Leadersh Manag Rev. 2004;18:155-159.
121. Lazarenko GC, Dobson C, Enokson R, et al. Accuracy and speed of urine pregnancy tests done in the emergency department: a prospective study. CJEM. 2001;3:292-295.
122. Allen KR, Harris CM. Measure of satisfaction of general practitioners with the chemical pathology services in Leeds Western Health District. Ann Clin Biochem. 1992;29:331-336.
123. Azam M, Nakhleh RE. Surgical pathology extradepartmental consultation practices. Arch Pathol Lab Med. 2002;126:405-412.
124. Dale JC, Novis DA, Meier FA. Reference laboratory telephone service quality. Arch Pathol Lab Med. 2001;125:608-612.
125. Pennington SJ, McClelland DB, Murphy WG. Clinicians' satisfaction with a hospital blood transfusion service: a marketing analysis of a monopoly supplier. Qual Health Care. 1993;2:239-242.
126. Rau J, Cross JL, Hofherr LK, et al. Physician satisfaction with human immunodeficiency virus type 1 and hepatitis B virus testing in San Diego County. Med Care. 1996;34:1-10.
127. Zarbo RJ, Nakhleh RE, Walsh M. Customer satisfaction in anatomic pathology: a College of American Pathologists Q-Probes study of 3065 physician surveys from 94 laboratories. Arch Pathol Lab Med. 2003;127:23-29.
128. Jones BA, Novis DA. Follow-up of abnormal gynecologic cytology: a College of American Pathologists Q-probes study of 16132 cases from 306 laboratories. Arch Pathol Lab Med. 2000;124:665-671.
129. Palm BTHM, Kant AC, Visser EA, et al. The effect of the family physician on improving follow-up after an abnormal Pap smear. Int J Qual Health Care. 1997;9:277-282.
130. Lavin C, Goodman E, Perlman S, et al. Follow-up of abnormal Papanicolaou smears in a hospital-based adolescent clinic. J Pediatr Adolesc Gynecol. 1997;10:141-145.
131. Wagner TH, Engelstad LP, McPhee SJ, et al. The costs of an outreach intervention for low-income women with abnormal Pap smears. Prev Chronic Dis. 2007;4:1-10.
132. Engelstad LP, Stewart S, Otero-Sabogal R, et al. The effectiveness of a community outreach intervention to improve follow-up among underserved women at highest risk for cervical cancer. Prev Med. 2005;41:741-748.
133. Agurto I, Sandoval J, de la Rosa M, et al. Improving cervical cancer prevention in a developing country, Int J Qual Health Care. 2006;18:81-86.
134. Hou SI. Stage of adoption and impact of direct-mail communications with and without phone intervention on Chinese women's cervical smear screening behavior. Prev Med. 2005;41:749-756.
135. Marcus AC, Kaplan CP, Crane LA, et al. Reducing loss-to-follow-up among women with abnormal Pap smears: results from a randomized trial testing an intensive follow-up protocol and economic incentives. Med Care. 1998;36:397-410.
136. Holloway RM, Wilkinson C, Peters TJ, et al. Cluster- randomised trial of risk communication to enhance informed uptake of cervical screening. Br J Gen Pract. 2003;53:620-625.
137. Sheridan SL, Harris RP, Woolf SH; Shared Decision-Making Workgroup of the US Preventive Services Task Force. Shared decision making about screening and chemoprevention: a suggested approach from the U.S. Preventive Services Task Force. Am J Prev Med. 2004;26:56-66.
138. Shahangian S. Laboratory-based health screening: perception of effectiveness, biases, utility, and informed/shared decision making. Lab Med. 2006;37:210-216.
139. Bu D, Pan E, Walker J, et al. Benefits of information technology-enabled diabetes management. Diabetes Care. 2007;30:1137-1142.
140. Rothschild JM, McGurk S, Honour M, et al. Assessment of education and computerized decision support interventions for improving transfusion practice. Transfusion. 2007;47:228-239.